Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Cutler

Showing results (51-60 of 166) with videos related to

Pageof 17
Sort By:
Archives of Neurology|February 1, 1986
Cerebrospinal fluid neuron-specific enolase is reduced in Alzheimer's diseaseN R Cutler, A D Kay, P J Marangos, et al.
The Annals of Pharmacotherapy|September 1, 1996
Placebo response in anxiety disordersM A Piercy, J J Sramek, N M Kurtz, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1992
Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.
American Journal of Hypertension|December 1, 1993
Compliance in hypertension: daily v twice dailyJ J Sramek, N R Cutler, R D Seifert, et al.
The New England Journal of Medicine|April 30, 1981
Depression-dependent dyskinesias in two cases of manic-depressive illnessN R Cutler, R M Post, A C Rey, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1995
The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in Alzheimer's diseaseJ J Sramek, N R Cutler, D J Hurley, et al.
Anxiety|January 1, 1994
Pilot study of a CCKB antagonist in patients with panic disorder: preliminary findingsJ J Sramek, M S Kramer, S A Reines, et al.
The Annals of Pharmacotherapy|September 1, 1992
Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2002
Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefitEzio Giacobini, R Spiegel, A Enz, et al.
Alzheimer Disease and Associated Disorders|January 1, 1995
Orthostasis in Alzheimer disease: a retrospective analysisS S Jhee, J J Sramek, T S Wardle, et al.
Pageof 17

Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
Archives of Neurology|February 1, 1986
Cerebrospinal fluid neuron-specific enolase is reduced in Alzheimer's diseaseN R Cutler, A D Kay, P J Marangos, et al.
The Annals of Pharmacotherapy|September 1, 1996
Placebo response in anxiety disordersM A Piercy, J J Sramek, N M Kurtz, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1992
Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.
American Journal of Hypertension|December 1, 1993
Compliance in hypertension: daily v twice dailyJ J Sramek, N R Cutler, R D Seifert, et al.
The New England Journal of Medicine|April 30, 1981
Depression-dependent dyskinesias in two cases of manic-depressive illnessN R Cutler, R M Post, A C Rey, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1995
The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in Alzheimer's diseaseJ J Sramek, N R Cutler, D J Hurley, et al.
Anxiety|January 1, 1994
Pilot study of a CCKB antagonist in patients with panic disorder: preliminary findingsJ J Sramek, M S Kramer, S A Reines, et al.
The Annals of Pharmacotherapy|September 1, 1992
Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2002
Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefitEzio Giacobini, R Spiegel, A Enz, et al.
Alzheimer Disease and Associated Disorders|January 1, 1995
Orthostasis in Alzheimer disease: a retrospective analysisS S Jhee, J J Sramek, T S Wardle, et al.
Pageof 17